Publication | Closed Access
A double-blind placebo-controlled randomized trial of adalimumab in the treatment of hidradenitis suppurativa
189
Citations
33
References
2011
Year
A significant reduction in HS severity was gained after 6 weeks. No long-term curative effect was uniformly seen.
| Year | Citations | |
|---|---|---|
Page 1
Page 1